Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Draft Common Data Elements Connect MS, Other Neurological Diseases

Executive Summary

NIH’s National Institute of Neurologic Disease and Stroke coordinated a project to get experts to agree on a set of common data elements for use in studies of different aspects of multiple sclerosis.

You may also be interested in...



With Google Ventures Backing, Flatiron Aims Broadly At Cancer Analytics

The New York City start-up brings together a product team well-versed in oncology with an IT crew that honed its skills in other arenas. Will their approach transform how we look at cancer data, or hit the snags that plague the entrenched industry?

Scientific Advances Increase Potential For Drugs To Treat ALS

New understanding of the spectrum of CNS disorders and rising interest from biotechs have revealed new targets, new biomarkers and new opportunities to treat the fast-acting and deadly neurodegenerative disease. Add to that an open stakeholder forum hosted by FDA Feb. 25 that could clarify regulatory and clinical expectations, and the tide may be turning on amyotrophic lateral sclerosis.

With Google Backing, Flatiron Aims Broadly At Cancer Analytics

The New York City start-up brings together a product team well-versed in oncology with an IT crew that honed its skills in other arenas. Will their approach transform how we look at cancer data, or hit the snags that plague the entrenched industry?

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054403

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel